Anupam Rasayan India Ltd (NSE: ANURAS, BSE: 543275) is a Surat, Gujarat-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹13,570 Cr, it ranks #497 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 13 in Custom Synthesis and Specialty CDMO. At ₹1,304.50 (as of 16 Nov 2026), the share price is 7.8% below its 52-week high of ₹1,415.00 and 22.2% above its 52-week low of ₹1,067.80. The share price is up 20.1% over one year and up 7.7% over three months.
| Current Price | ₹1,304.50 |
|---|---|
| Market Cap | ₹13,570 Cr |
| NSE Symbol | ANURAS |
| BSE Code | 543275 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | 79.6 |
| Return on Equity | 5.76% |
| Return on Assets | 3.66% |
| 52-Week Range | ₹1,067.80 – ₹1,415.00 |
| 1-Year Price Change | +20.1% |
| 3-Month Price Change | +7.7% |
| Beta (1Y) | -0.24 |
| Dividend Yield | 0.12% |
| Headquarters | Surat, Gujarat |
| Website | www.anupamrasayan.com |
| Revenue | ₹806 Cr |
|---|---|
| Net Profit | ₹65 Cr |
| Net Margin | 8.1% |
| EPS (Basic) | ₹4.39 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Anupam Rasayan India Ltd reported revenue of ₹806 Cr in Q2 FY27, up 10.2% from ₹731 Cr in Q2 FY26 and up 23.0% from ₹655 Cr in Q1 FY27. It posted a net profit of ₹65 Cr for the quarter, against a net profit of ₹57 Cr in Q2 FY26 (up 13.7%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹486 Cr (Q1 FY26) to ₹806 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹806 Cr | ₹65 Cr | 8.1% |
| Q1 FY27 | ₹655 Cr | ₹51 Cr | 7.8% |
| Q4 FY26 | ₹636 Cr | ₹56 Cr | 8.8% |
| Q3 FY26 | ₹512 Cr | ₹61 Cr | 11.8% |
| Q2 FY26 | ₹731 Cr | ₹57 Cr | 7.8% |
| Q1 FY26 | ₹486 Cr | ₹48 Cr | 10.0% |
| Q4 FY25 | ₹500 Cr | ₹63 Cr | 12.6% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 59.07% of Anupam Rasayan India Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 63.8% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
1. Manufacturing of Industrial Chemicals-This segment engages in the custom synthesis business; and manufacturing of specialty chemicals.
1. Manufacturing of Industrial Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,570 Cr | 79.6 | 5.76% | ₹806 Cr | +20.1% |
| Neogen Chemicals Limited (Neogen) | ₹8,322 Cr | 259.2 | 3.58% | ₹296 Cr | +93.4% |
| Prasol Chemicals Limited | ₹4,681 Cr | 58.1 | — | ₹413 Cr | — |
| Laxmi Organic Industries Ltd | ₹4,574 Cr | 57.2 | 4.08% | ₹1,083 Cr | -18.9% |
| Tatva Chintan Pharma Chem Ltd | ₹3,871 Cr | 92.5 | 5.53% | ₹217 Cr | +12.2% |
| Paushak Ltd. | ₹1,487 Cr | 38.1 | 8.22% | ₹89 Cr | — |
| Sunshield Chemicals Ltd. | ₹833 Cr | 25.2 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹733 Cr | 31.8 | 4.80% | ₹65 Cr | -12.8% |
| Resonance Specialties Ltd. | ₹327 Cr | 31.5 | 15.15% | — | +203.4% |
Listed by market capitalisation. Ratios are shown for context only.
Anupam Rasayan India Ltd is trading at ₹1,304.50, with a market capitalisation of ₹13,570 Cr.
Anupam Rasayan India Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Anupam Rasayan India Ltd has a P/E of 79.6 and a return on equity of 5.76%.
Anupam Rasayan India Ltd is listed on the NSE under the symbol ANURAS and on the BSE under the scrip code 543275.
Anupam Rasayan India Ltd's share price is up 20.1% over one year and up 7.7% over three months. Its 52-week range is ₹1,067.80 to ₹1,415.00.
In Q2 FY27, Anupam Rasayan India Ltd reported revenue of ₹806 Cr and net profit of ₹65 Cr, with basic EPS of ₹4.39 (consolidated, parsed from the company's exchange filing).
Anupam Rasayan India Ltd reported revenue of ₹806 Cr in Q2 FY27, up 10.2% from ₹731 Cr in Q2 FY26 and up 23.0% from ₹655 Cr in Q1 FY27.
Promoters held 59.07% of Anupam Rasayan India Ltd's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.